352 related articles for article (PubMed ID: 28813659)
21. A MyD88/IL1R Axis Regulates PD-1 Expression on Tumor-Associated Macrophages and Sustains Their Immunosuppressive Function in Melanoma.
Tartey S; Neale G; Vogel P; Malireddi RKS; Kanneganti TD
Cancer Res; 2021 May; 81(9):2358-2372. PubMed ID: 33619117
[TBL] [Abstract][Full Text] [Related]
22. Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.
Zhang Z; Jin Y; Zhang W; Chu C; Zhang K; Gao X; Zhou J; Zou L; Tang F; Wang H; Zou Q
J Clin Lab Anal; 2020 May; 34(5):e23162. PubMed ID: 31867779
[TBL] [Abstract][Full Text] [Related]
23. Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell Homeostasis.
Ito K; Lee J; Chrysanthou S; Zhao Y; Josephs K; Sato H; Teruya-Feldstein J; Zheng D; Dawlaty MM; Ito K
Cell Rep; 2019 Sep; 28(10):2480-2490.e4. PubMed ID: 31484061
[TBL] [Abstract][Full Text] [Related]
24. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
25. Structural insight into substrate preference for TET-mediated oxidation.
Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
[TBL] [Abstract][Full Text] [Related]
26. Dual mechanisms of posttranscriptional regulation of Tet2 by Let-7 microRNA in macrophages.
Jiang S; Yan W; Wang SE; Baltimore D
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12416-12421. PubMed ID: 31160465
[TBL] [Abstract][Full Text] [Related]
27. Induction of DEAD Box helicase 5 in early adipogenesis is regulated by Ten-eleven translocation 2.
Cho M; Lee E; Shon J; Choi MJ; Park JH; Park YJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jul; 1865(7):158684. PubMed ID: 32169654
[TBL] [Abstract][Full Text] [Related]
28. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
29. Silencing HIF-1α induces TET2 expression and augments ascorbic acid induced 5-hydroxymethylation of DNA in human metastatic melanoma cells.
Fischer AP; Miles SL
Biochem Biophys Res Commun; 2017 Aug; 490(2):176-181. PubMed ID: 28601635
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Anti-melanoma Efficacy of a Pim-3-Targeting Bifunctional Small Hairpin RNA via Single-Stranded RNA-Mediated Activation of Plasmacytoid Dendritic Cells.
Liu J; Hu Y; Guo Q; Yu X; Shao L; Zhang C
Front Immunol; 2019; 10():2721. PubMed ID: 31849942
[TBL] [Abstract][Full Text] [Related]
31. PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.
Song C; Wang L; Wu X; Wang K; Xie D; Xiao Q; Li S; Jiang K; Liao L; Yates JR; Lee JD; Yang Q
Cancer Res; 2018 May; 78(10):2475-2489. PubMed ID: 29735542
[TBL] [Abstract][Full Text] [Related]
32. Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression.
Nakatsukasa H; Oda M; Yin J; Chikuma S; Ito M; Koga-Iizuka M; Someya K; Kitagawa Y; Ohkura N; Sakaguchi S; Koya I; Sanosaka T; Kohyama J; Tsukada YI; Yamanaka S; Takamura-Enya T; Lu Q; Yoshimura A
Int Immunol; 2019 Apr; 31(5):335-347. PubMed ID: 30726915
[TBL] [Abstract][Full Text] [Related]
33. MBD3L2 promotes Tet2 enzymatic activity for mediating 5-methylcytosine oxidation.
Peng L; Li Y; Xi Y; Li W; Li J; Lv R; Zhang L; Zou Q; Dong S; Luo H; Wu F; Yu W
J Cell Sci; 2016 Mar; 129(5):1059-71. PubMed ID: 26769901
[TBL] [Abstract][Full Text] [Related]
34. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma.
Weber R; Riester Z; Hüser L; Sticht C; Siebenmorgen A; Groth C; Hu X; Altevogt P; Utikal JS; Umansky V
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788238
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies.
Zeng H; He H; Guo L; Li J; Lee M; Han W; Guzman AG; Zang S; Zhou Y; Zhang X; Goodell MA; King KY; Sun D; Huang Y
Cancer Lett; 2019 Dec; 467():1-8. PubMed ID: 31563562
[TBL] [Abstract][Full Text] [Related]
36. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.
Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T
PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482
[TBL] [Abstract][Full Text] [Related]
37. CCR5
Blattner C; Fleming V; Weber R; Himmelhan B; Altevogt P; Gebhardt C; Schulze TJ; Razon H; Hawila E; Wildbaum G; Utikal J; Karin N; Umansky V
Cancer Res; 2018 Jan; 78(1):157-167. PubMed ID: 29089297
[TBL] [Abstract][Full Text] [Related]
38. A Novel Function of TET2 in CNS: Sustaining Neuronal Survival.
Mi Y; Gao X; Dai J; Ma Y; Xu L; Jin W
Int J Mol Sci; 2015 Sep; 16(9):21846-57. PubMed ID: 26378518
[TBL] [Abstract][Full Text] [Related]
39. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.
Fleming V; Hu X; Weller C; Weber R; Groth C; Riester Z; Hüser L; Sun Q; Nagibin V; Kirschning C; Bronte V; Utikal J; Altevogt P; Umansky V
Cancer Res; 2019 Sep; 79(18):4715-4728. PubMed ID: 31337655
[TBL] [Abstract][Full Text] [Related]
40. Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.
Zhao Z; Chen L; Dawlaty MM; Pan F; Weeks O; Zhou Y; Cao Z; Shi H; Wang J; Lin L; Chen S; Yuan W; Qin Z; Ni H; Nimer SD; Yang FC; Jaenisch R; Jin P; Xu M
Cell Rep; 2015 Nov; 13(8):1692-704. PubMed ID: 26586431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
